What blood tests are used to monitor Ovarian Cancer

Blood Tests for Ovarian Cancer Monitoring

I'm glad you're asking about this—understanding what your blood tests measure is an important part of managing your care. Let me explain the main blood markers used to monitor ovarian cancer.

Primary Marker: CA-125

CA-125 is the most commonly used blood test for ovarian cancer monitoring. According to the NCCN Guidelines, CA-125 levels tend to correlate with how your disease is progressing, especially if your levels were elevated before treatment started.

What it measures: CA-125 is a protein that cancer cells often produce in higher amounts than healthy cells.

How it's used:

• Before treatment: Helps assess the extent of disease and aids in treatment planning
• During treatment: Tracks how well chemotherapy is working—levels typically drop if treatment is effective
• After treatment: Monitors for signs of recurrence (cancer returning)

Important context: CA-125 can be elevated in non-cancerous conditions too (like endometriosis or menstruation), so it's not used alone for diagnosis. It's most useful when tracked over time to see trends.

Secondary Marker: HE4

HE4 (Human Epididymal Protein 4) is another marker that NCCN Guidelines mention may be useful, particularly in certain situations:

• Some doctors test HE4 in patients whose CA-125 is not elevated, since HE4 can be helpful for future monitoring
• Research suggests HE4 may help detect recurrence earlier than CA-125 alone in some patients
• However, the NCCN Guidelines note that results vary across studies, so HE4 is not routinely recommended as standard preoperative testing

Other Markers (Less Common Ovarian Cancer Types)

Depending on your specific ovarian cancer type, your doctor may also monitor:

• AFP (Alpha-fetoprotein) - for germ cell tumors
• Beta-hCG (Human chorionic gonadotropin) - for germ cell tumors
• LDH (Lactate dehydrogenase) - for germ cell tumors and dysgerminomas
• Inhibin - for granulosa cell tumors (a type of sex cord-stromal tumor)
• CEA and CA19-9 - occasionally used depending on tumor characteristics

How Monitoring Works in Practice

According to NCCN Guidelines, your oncologist will:

1. Establish baseline levels before or at the start of treatment
2. Track changes over time rather than focusing on single values
3. Correlate results with imaging (CT scans, ultrasounds) and how you're feeling clinically
4. Adjust monitoring frequency based on your treatment phase and response

Important Questions to Ask Your Doctor

Since blood test interpretation is very individual, consider asking:

1. Which markers are you monitoring for my specific type of ovarian cancer?
2. What were my baseline levels before treatment, and what are my current levels?
3. What does a "normal" range mean for me, and how do you interpret trends in my results?
4. How often will we check these markers, and will that change based on my treatment response?
5. If my levels rise, what does that mean, and what's the next step?

Key Takeaway

Blood markers like CA-125 and HE4 are valuable tools for tracking your ovarian cancer over time, but they work best when interpreted as part of your complete clinical picture—including imaging, physical exams, and how you're feeling. Your oncologist will use these results to guide treatment decisions and monitor for recurrence.

According to the NCCN Guidelines for Ovarian Cancer, serum CA-125 levels correlate with clinical course and can be useful for monitoring response to therapy and surveillance for recurrence, making regular monitoring an important part of your follow-up care.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific blood tests and what your individual results mean.